Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The STOP-PASC Randomized Clinical Trial

LN Geng, H Bonilla, H Hedlin, KB Jacobson… - JAMA Internal … - jamanetwork.com
Importance There is an urgent need to identify treatments for postacute sequelae of SARS-
CoV-2 infection (PASC). Objective To assess the efficacy of a 15-day course of nirmatrelvir …
被引用次数：3 相关文章

Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The STOP-PASC Randomized Clinical Trial

LN Geng, H Bonilla, H Hedlin, KB Jacobson… - JAMA internal … - pubmed.ncbi.nlm.nih.gov
Importance There is an urgent need to identify treatments for postacute sequelae of SARS-
CoV-2 infection (PASC). Objective To assess the efficacy of a 15-day course of nirmatrelvir …

Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The STOP-PASC Randomized Clinical Trial.

LN Geng, H Bonilla, H Hedlin, KB Jacobson… - JAMA Internal …, 2024 - europepmc.org
Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2
Infection: The STOP-PASC Randomized Clinical Trial. - Abstract - Europe PMC Sign in | Create …
[HTML] nih.gov

[HTML][HTML] Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The STOP-PASC Randomized Clinical Trial

LN Geng, H Bonilla, H Hedlin, KB Jacobson… - JAMA Internal … - ncbi.nlm.nih.gov
Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2
Infection - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …